Protalix BioTherapeutics
PLX
#8318
Rank
NZ$0.39 B
Marketcap
NZ$4.89
Share price
0.34%
Change (1 day)
4.20%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): NZ$0.02662

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.03361. In 2024 the company made an earnings per share (EPS) of NZ$0.06722 a decrease over its 2023 EPS that were of NZ$0.20.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.02662-60.39%
2024NZ$0.06722-66.67%
2023NZ$0.20-138.71%
2022NZ-$0.52-50%
2021NZ-$1.04181.82%
2020NZ-$0.37-82.11%
2019NZ-$2.07-31.67%
2018NZ-$3.02-72.31%
2017NZ-$10.92124.14%
2016NZ-$4.87-147.54%
2015NZ$10.25-290.62%
2014NZ-$5.386.67%
2013NZ-$5.04130.77%
2012NZ-$2.18-69.77%
2011NZ-$7.2319.44%
2010NZ-$6.05-12.2%
2009NZ-$6.8936.67%
2008NZ-$5.04-37.5%
2007NZ-$8.0750%
2006NZ-$5.383.23%
2005NZ-$5.21138.46%
2004NZ-$2.18-74%
2003NZ-$8.40-0%
2002NZ-$8.40-50%
2001NZ-$16.81233.33%
2000NZ-$5.04-84.21%
1999NZ-$31.93-24%
1998NZ-$42.01-600%
1997NZ$8.40-16.67%
1996NZ$10.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.89 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$7.24 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.18-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.06 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel